Skip to main content
S&P 5007,389.63-3.89%DOW51,733.72-3.04%NASDAQ24,404.93-5.17%BTC$75,779.00-5.70%ETH$2,249.97-7.14%GOLD$4,117.00+1.08%OIL$90.41+2.60%
Smart Investors Daily
SID Premium
VI

OTC · VICP

VICAPSYS LIFE SCIENCES

Healthcare · Biotechnology

$0.50

Up+$0.00 (+0.00%)

Updated Nov 5, 2026, 6:03 PM

SID Score

4.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
48.56M
P/E ratio
-62.85
Dividend yield
0.00%
52-week range
— – —
Volume
1.4K
Avg. volume
26

Price performance · VICP

VICP price history

1M range · 0 trading sessions · Daily adjusted prices

VICP does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest VICP news

The latest Smart Investors Daily articles mentioning VICP.

Stock researchCompany · Overview

VICP research

Overview

Company profile and research snapshot.

Company profile

VICAPSYS LIFE SCIENCES

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 5, 2026

Housekeeping Starts with Branding: Vicapsys Life Sciences Adopts New Corporate Identity Developed by FutureBrand for Vicapsys and Its Stateline Subsidiary

(OTC PINK:VICP) ("VICP" or the "Company") today announced that FutureBrand, the global brand consultancy behind the corporate identities of Sanofi, GSK and Merck, has onboarded the Company as a client through its Latin America practice and delivered a new corporate identity for Vicapsys Life Sciences and its wholly owned subsidiary, of Puerto Rico, Inc. The rollout of the new identity is the first in a series of corporate housekeeping steps the Company is completing following its reverse merger

Yahoo · Sep 23, 2026

RETRANSMISSION: Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal and Underserved Markets

(OTC PINK:VICP) ("VICP" or the "Company") today announced that it has completed its reverse merger with of Puerto Rico, Inc. ("Stateline"), effective September 3, 2026, and has entered into a definitive asset purchase agreement to acquire the FDA-approved NitroMist® (nitroglycerin) lingual aerosol product.

Yahoo · Sep 22, 2026

Vicapsys Life Sciences Completes Reverse Merger with Stateline Distributors of Puerto Rico and Signs Definitive Agreement to Acquire NitroMist(R), Creating a Vertically Integrated Pharmaceutical Manufacturing and Distribution Platform Serving Federal, Tribal and Underserved Markets

(OTC PINK:VICP) ("VICP" or the "Company") today announced that it has completed its reverse merger with of Puerto Rico, Inc. ("Stateline"), effective September 3, 2026, and has entered into a definitive asset purchase agreement to acquire the FDA-approved NitroMist® (nitroglycerin) lingual aerosol product.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By